Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2006; 12(36): 5846-5852
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5846
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5846
Plasma 8-isoprostane (ng/L) | Group III vsGroup I | Group III vsGroup I | |||
Group I | Group II | Group III | |||
Total | 20.3 ± 6.1 (n = 64) | 20.9 ± 5.7 (n = 56) | 26.6 ± 9.5 (n = 37) | t = 4.059 P < 0.0001 (CI: 3.222-9.387) | t = 3.587 P < 0.001 (CI: 2.523-8.783) |
Male | 22.5 ± 6.3 (n = 32) | 21.1 ± 4.9 (n = 31) | 23.7 ± 8.0 (n = 20) | t = 0.589 N.S. (CI: -2.832-5.181) | t = 1.464 N.S. (CI: -0.981-6.252) |
Female | 18.1 ± 5.0 (n = 32) | 20.8 ± 6.6 (n = 25) | 30.0 ± 10.3 (n = 17) | t = 5.494 P < 0.0001 (CI: 7.572-16.321) | t = 3.542 P < 0.005 (CI: 3.954-14.466) |
- Citation: Kitano S, Hisatomi H, Hibi N, Kawano K, Harada S. Improved method of plasma 8-Isoprostane measurement and association analyses with habitual drinking and smoking. World J Gastroenterol 2006; 12(36): 5846-5852
- URL: https://www.wjgnet.com/1007-9327/full/v12/i36/5846.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i36.5846